Cost-Utility Evaluation Of Insulin Glargine (300 U/ML) Versus Insulin Glargine (100 U/ML) And Insulin Degludec (100 U/ML) In Patients With Type 2 Diabetes Mellitus In Slovenia

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.466
https://www.valueinhealthjournal.com/article/S1098-3015(17)30800-8/fulltext
Title : Cost-Utility Evaluation Of Insulin Glargine (300 U/ML) Versus Insulin Glargine (100 U/ML) And Insulin Degludec (100 U/ML) In Patients With Type 2 Diabetes Mellitus In Slovenia
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30800-8&doi=10.1016/j.jval.2017.08.466
First page : A481
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 441
Categories :
Tags :
Regions :
ViH Article Tags :